Monograph Title | Section | Source Publication | Page Number | Errata Post Date Sort ascending | Errata Official Date | Target Errata Print Publication | Target Online Fix Publication | Description |
---|---|---|---|---|---|---|---|---|
ONDANSETRON INJECTION | Assay | USP43–NF38 | 3265 | 30-Jul-2021 | 1-Aug-2021 | NA | NA | In Chromatographic system: Change The liquid chromatograph is equipped with a 216-nm detector and a 4.6-mm × 20-cm column that contains packing L10. to: The liquid chromatograph is equipped with a 216-nm detector and a 4.6-mm × 25-cm column that… Read More |
GEMCITABINE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | 2093 | 30-Jul-2021 | 1-Aug-2021 | NA | NA | In USP Cytosine RS: Change 2(1H)-Pyrimidinone, 4-amino-. to: Cytosine. |
QUAZEPAM TABLETS | ADDITIONAL REQUIREMENTS/USP Reference standards <11> | USP43–NF38 | 3791 | 30-Jul-2021 | 1-Aug-2021 | NA | NA | In USP Quazepam Related Compound A RS: Change 7-Chloro-1-(2,2,2 trifluoroethyl)-5-(2-Fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepine-2-one. to: 7-Chloro-5-(2-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepine-2-one. |
CODEINE PHOSPHATE TABLETS | Limit of morphine | USP43–NF38 | 1139 | 30-Jul-2021 | 1-Aug-2021 | NA | NA | Change A 1-mL portion of the filtrate from Identification test B meets the requirements of the test for Limit of morphine under Codeine Phosphate. to: Dissolve about 50 mg of potassium ferricyanide in 10 mL of water, and… Read More |
CLOZAPINE | IMPURITIES/Organic Impurities | USPNF 2021 ISSUE 1 | Online | 25-Jun-2021 | 1-Jul-2021 | NA | NA | In Table 2: Change Demethyl clozapin to: Demethyl clozapine |
DACTINOMYCIN | CHEMICAL INFORMATION | USP43–NF38 | Online | 25-Jun-2021 | 1-Jul-2021 | NA | NA | Please see the updated chemical structure at online.uspnf.com |
AMIODARONE HYDROCHLORIDE INJECTION | IMPURITIES/Limit of Iodide | USP43–NF38 | 254 | 25-Jun-2021 | 1-Jul-2021 | NA | NA | In Potassium iodate solution: Change 10.7 g/L of potassium iodide in water to: 10.7 g/L of potassium iodate in water |
AMITRIPTYLINE HYDROCHLORIDE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | 263 | 25-Jun-2021 | 1-Jul-2021 | NA | NA | In USP Amitriptyline Related Compound B RS: Change 295.42 to: 295.43 |
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE TABLETS | ADDITIONAL REQUIREMENTS/USP References Standards <11> | Revision Bulletin (Official May 01, 2021) | Online | 25-Jun-2021 | 1-Jul-2021 | NA | NA | In USP Benazepril Related Compound B RS: Change (3S) 3-[[(1R) 1-(Ethoxycarbonyl)-3-phenylpropyl] amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid, monohydrochloride; Also known as 2-[(SR)-3-{[(RS… Read More |
KETOROLAC TROMETHAMINE | IMPURITIES/Organic Impurities | USP43–NF38 | 2513 | 25-Jun-2021 | 1-Jul-2021 | NA | NA | Change Mobile phase, Diluent, System suitability solution, Standard solution, and Sample solution: Proceed as directed in the Assay. to: Mobile phase, Diluent, System suitability solution, Standard solution, Sample… Read More |
BENAZEPRIL HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP References standards <11> | USP43–NF38 | 488 | 25-Jun-2021 | 1-Jul-2021 | NA | NA | In USP Benazepril Related Compound A RS: Change (3R) 3-[[(1R) 1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid, monohydrochloride. to: 2-[(R)-3-{[(R)-1-Ethoxy-1-oxo-4… Read More |
METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS | PERFORMANCE TESTS/Dissolution <711> | Revision Bulletin (Official March 01, 2021) | Online | 25-Jun-2021 | 1-Jul-2021 | NA | NA | In Test 14/Analysis: Delete Result4 = {(C4 × V) + [(C3 + C2 + C1) × VS]} × (1/L) × 100 |
LANSOPRAZOLE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | 2551 | 25-Jun-2021 | 1-Jul-2021 | NA | NA | In USP Lansoprazole Related Compound B RS: Change 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-pyridin-2-yl] methyl]sulfanyl]-1H-benzimidazole. C16H14F3N3OS 353.36 to: 2-{[(3-Methyl-4-(2,2,2-… Read More |
GLYBURIDE | CHEMICAL INFORMATION | USP43–NF38 | 2125 | 25-Jun-2021 | 1-Jul-2021 | NA | NA | Change 1-[[p-[2-(5-Chloro-o-anisamido)ethyl]phenyl]sulfonyl]-3-cyclohex-ylurea to: 1-[[p-[2-(5-Chloro-o-anisamido)ethyl]phenyl]sulfonyl]-3-cyclohexylurea |
NORTRIPTYLINE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF 2021 ISSUE 1 | Online | 25-Jun-2021 | 1-Jul-2021 | NA | NA | In USP Amitriptyline Related Compound B RS: Change 295.42 to: 295.43 |
BENAZEPRIL HYDROCHLORIDE TABLETS | ADDITIONAL REQUIREMENTS/USP References Standards <11> | USP43–NF38 | Online | 25-Jun-2021 | 1-Jul-2021 | NA | NA | In USP Benazepril Related Compound B RS: Change (3S)-3-[[(1R)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid, monohydrochloride; Also known as 2-[(SR)-3-{[(RS)-1-… Read More |
AMITRIPTYLINE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | Online | 28-May-2021 | 1-Jun-2021 | NA | NA | In USP Amitriptyline Related Compound B RS: Change 295.42 to: 295.43 |
CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE TABLETS | ASSAY/Procedure | USP43–NF38 | 938 | 28-May-2021 | 1-Jun-2021 | NA | NA | In Analysis: Change 313.86 to: 313.87 |
GARLIC FLUIDEXTRACT | COMPOSITION/Content of S-Allyl-L-cysteine | USP43–NF38 | 5023 | 28-May-2021 | 1-Jun-2021 | NA | NA | In Analysis: Change Calculate the percentage of S-allyl-L-cysteine (C6H11SN) in the portion of Fluidextract taken: to: Calculate the percentage of S-allyl-L-cysteine in the portion of Fluidextract taken: |
HYDROXYZINE PAMOATE | IMPURITIES/Organic Impurities | USP43–NF38 | 2269 | 28-May-2021 | 1-Jun-2021 | NA | NA | In System suitability/Suitability requirements/Resolution: Change 4-chlorobenophenone to: 4-chlorobenzophenone |
CARBOMER HOMOPOLYMER | CHEMICAL INFORMATION | USPNF 2021 ISSUE 1 | Online | 28-May-2021 | 1-Jun-2021 | NA | NA | Please see the updated chemical structure at https://online.uspnf.com |
GADOTERATE MEGLUMINE INJECTION | OTHER COMPONENTS/Content of Meglumine | USPNF 2021 ISSUE 1 | Online | 28-May-2021 | 1-Jun-2021 | NA | NA | In Analysis: Change Result = (a/α) × (1/l) × (1/L) × 100 to: Result = (a/α) × 100 × (1/l) × (1/L) × 100 |
CARBOMER COPOLYMER | IMPURITIES | USPNF 2021 ISSUE 1 | Online | 28-May-2021 | 1-Jun-2021 | NA | NA | In Limit of Ethyl Acetate and Cyclohexane/Analysis: Change Samples: Standard stock solution, Standard solution A, Standard solution B, Standard solution C, and Sample solution to: Samples: Standard solution A, Standard… Read More |
CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE TABLETS | PERFORMANCE TESTS/Dissolution <711> | USP43–NF38 | 938 | 28-May-2021 | 1-Jun-2021 | NA | NA | In Analysis: Change 313.86 to: 313.87 |
BIFIDOBACTERIUM LONGUM SUBSP. LONGUM | DEFINITION | USPNF 2021 ISSUE 1 | Online | 28-May-2021 | 1-Jun-2021 | NA | NA | Change Bifidobacteriumlongum subsp. longum comprises to: Bifidobacterium longum subsp. longum comprises |
AMITRIPTYLINE HYDROCHLORIDE | CHEMICAL INFORMATION | USP43–NF38 | Online | 28-May-2021 | 1-Jun-2021 | NA | NA | Change 313.86 to: 313.87 |
CARBOMER INTERPOLYMER | IMPURITIES | USPNF 2021 ISSUE 1 | Online | 28-May-2021 | 1-Jun-2021 | NA | NA | In Limit of Ethyl Acetate and Cyclohexane/Analysis: Change Samples: Standard stock solution, Standard solution A, Standard solution B, Standard solution C, and Sample solution to: Samples: Standard solution A, Standard… Read More |
MINOXIDIL TABLETS | IMPURITIES/Organic Impurities | USPNF 2021 ISSUE 1 | Online | 28-May-2021 | 1-Jun-2021 | NA | NA | In Analysis: Change Result = (rU/rS) × (CU/CS) × 100 to: Result = (rU/rS) × (CS/CU) × 100 |
HYDROXYZINE PAMOATE CAPSULES | ASSAY/Procedure | USP43–NF38 | 2271 | 28-May-2021 | 1-Jun-2021 | NA | NA | In System suitability/Suitability requirements/Resolution: Change 4-chlorobenophenone, to: 4-chlorobenzophenone, |
CARBOMER HOMOPOLYMER | IMPURITIES | USPNF 2021 ISSUE 1 | Online | 28-May-2021 | 1-Jun-2021 | NA | NA | In Limit of Ethyl Acetate and Cyclohexane/Analysis: Change Samples: Standard stock solution, Standard solution A, Standard solution B, Standard solution C, and Sample solution to: Samples: Standard solution A, Standard… Read More |
CLOZAPINE | CHEMICAL INFORMATION | USPNF 2021 ISSUE 1 | Online | 28-May-2021 | 1-Jun-2021 | NA | NA | Change 326.82 to: 326.83 |
OIL- AND WATER-SOLUBLE VITAMINS WITH MINERALS CHEWABLE GELS | STRENGTH | USPNF 2021 ISSUE 1 | Online | 30-Apr-2021 | 1-May-2021 | NA | NA | In Vitamins B3 (as Niacinamide), B6, and Folic Acid, Method 1/System suitability: Change [Note—The relative retention times for niacinamide, pyridoxine, and folic acid are about 1.0, 1.6, 2.0, and 3.0 respectively.] to: [Note—The relative… Read More |
CARBOMER INTERPOLYMER | CHEMICAL INFORMATION | USPNF 2021 ISSUE 1 | Online | 30-Apr-2021 | 1-May-2021 | NA | NA | Please see the updated chemical structure at online.uspnf.com |
DOXEPIN HYDROCHLORIDE CAPSULES | PERFORMANCE TESTS/Dissolution <711> | Revision Bulletin (Official May 01, 2021) | Online | 30-Apr-2021 | 1-May-2021 | NA | NA | In Test 1/Analysis: Change L = label claim of doxepin hydrochloride (mg/Capsule) to: L = label claim (mg/Capsule) |
AZITHROMYCIN FOR ORAL SUSPENSION | PERFORMANCE TESTS/Dissolution <711> | USPNF 2021 ISSUE 1 | Online | 30-Apr-2021 | 1-May-2021 | NA | NA | In Medium: Change Sodium phosphate buffer, pH of 6.0 (14.2 g/L of disodium hydrogen orthophosphate anhydrous in water, adjusted with dilute hydrochloric acid to a pH of 6.0) to: Sodium phosphate buffer, pH 6.0 (14.2 g/L of sodium phosphate,… Read More |
MALTITOL SOLUTION | IMPURITIES/Limit of Nickel | USPNF 2021 ISSUE 1 | Online | 30-Apr-2021 | 1-May-2021 | NA | NA | Change Solution A: [Note—Prepare this solution fresh weekly.] to: Standard nickel solution A: [Note—Prepare this solution fresh weekly.] |
CARBOMER INTERPOLYMER | IMPURITIES/Limit of Acrylic Acid | USPNF 2021 ISSUE 1 | Online | 30-Apr-2021 | 1-May-2021 | NA | NA | In Analysis: Change CU = concentration of Carbomer Interpolymer in the Sample solution (g) to: CU = concentration of Carbomer Interpolymer in the Sample solution (mg/g) |
AZITHROMYCIN FOR ORAL SUSPENSION | ASSAY/Procedure | USPNF 2021 ISSUE 1 | Online | 30-Apr-2021 | 1-May-2021 | NA | NA | In Solution A: Change orthophosphoric acid to: phosphoric acid |
CARBOPROST TROMETHAMINE | CHEMICAL INFORMATION | USP43–NF38 | 771 | 30-Apr-2021 | 1-May-2021 | NA | NA | Change 489.64 to: 489.65 AND Change (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(E)-(3S)-3-hydroxy-3-methyl-1-octenyl]cyclopentyl]-5-heptenoic acid compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol… Read More |
SERTRALINE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF 2021 ISSUE 1 | Online | 26-Mar-2021 | 1-May-2021 | NA | NA | In USP Sertraline Hydrochloride Racemic Mixture RS: Change C17H17Cl2 · HCl to: C17H17Cl2N · HCl |
RILUZOLE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | 3883 | 26-Mar-2021 | 1-Apr-2021 | NA | NA | In USP Riluzole Related Compound A RS: Change 4-Trifluoromethoxyaniline. C7H6F3NO 177.12 to: 4-(Trifluoromethoxy)aniline. C7H6F3NO 177.13 |
MIRTAZAPINE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | Online | 26-Mar-2021 | 1-Apr-2021 | NA | NA | In USP Mirtazapine Resolution Mixture RS: Change Impurity D: 1,2,3,4,10,14b-Hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine. to: Impurity D: [Note–This impurity may be available either as the free base form or as the hydrochloride salt… Read More |
<659> PACKAGING AND STORAGE REQUIREMENTS | GENERAL DEFINITIONS/Packaging Definitions | Second Supplement to USP43–NF38 | Online | 26-Mar-2021 | 1-Dec-2025 | NA | NA | In Light-resistant container: Change 〈661.2〉, Functionality, Spectral Transmission Requirements for Light-Resistant Components and Systems. to: 〈661.2〉, Functionality Test Method, Spectral Transmission Requirements for Light-… Read More |
GENERAL NOTICES AND REQUIREMENTS | 2. OFFICIAL STATUS AND LEGAL RECOGNITION | USPNF 2021 ISSUE 1 | Online | 26-Mar-2021 | 1-May-2021 | NA | NA | In 2.10. Official Text: Change http://www.uspnf.com. to: https://online.uspnf.com. |
CARBOMER COPOLYMER | CHEMICAL INFORMATION | USPNF 2021 ISSUE 1 | Online | 26-Mar-2021 | 1-May-2021 | NA | NA | See online.uspnf.com for correction |
GLYBURIDE AND METFORMIN HYDROCHLORIDE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | 2128 | 26-Mar-2021 | 1-Apr-2021 | NA | NA | In USP Glyburide Related Compound A RS: Change 368.84 to: 368.83 |
AMPICILLIN | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | 316 | 26-Mar-2021 | 1-Apr-2021 | NA | NA | In USP Amoxicillin Related Compound A RS: Change (2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid. C16H14N2O2 266.29 to: (2S,5… Read More |
TRIHEXYPHENIDYL HYDROCHLORIDE TABLETS | IMPURITIES/Organic Impurities | USP43–NF38 | 4519 | 26-Mar-2021 | 1-Apr-2021 | NA | NA | In Sample solution: Change Nominally 1 mg/mL of trihexyphenidyl hydrochloride in Diluent prepared as follows. to: Nominally 1 mg/mL of trihexyphenidyl hydrochloride prepared as follows. |
RILUZOLE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | 3882 | 26-Mar-2021 | 1-Apr-2021 | NA | NA | In USP Riluzole Related Compound A RS: Change 4-Trifluoromethoxyphenylamine; 4-trifluoromethoxyanaline. C7H6F3NO 177.12 to: 4-(Trifluoromethoxy)aniline. C7H6F3NO 177.… Read More |
MIRTAZAPINE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | Online | 26-Mar-2021 | 1-Apr-2021 | NA | NA | In USP Mirtazapine Resolution Mixture RS: Change Impurity D: 1,2,3,4,10,14b-Hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine. to: Impurity D: [Note–This impurity may be available either as the free base form or as the hydrochloride salt… Read More |